Free · 13,591 studies indexed

lighttherapyresearch.com is a free index of research on photobiomodulation and light therapy, gathered from the world’s journals and trial registries.

Sections
Eye, Ear & Vision

Refractive surgery and dry eye

Topical anti-inflammatory agents (Cyclosporine 0.1%, hydrocortisone phosphate, fluorometholone) should be used for 3-6 months in cases of ocular surface damage.

Excerpt from the paper’s abstract. Read the full paper for the details.

AI-generated summary

This review discusses dry eye disease (DED) in people undergoing corneal refractive surgery, noting that its incidence varies across studies and that untreated pre-existing DED is a risk factor for post-surgical dry eye symptoms. The authors describe management recommendations for the ocular surface before and after surgery, based on evidence and clinical experience. The abstract does not report any photobiomodulation or red or near-infrared light therapy.

Who or what was studied
People undergoing corneal refractive surgery, including those with pre-existing dry eye disease
Limits stated in the abstract
The abstract does not state the number of studies or patients reviewed, and the recommendations are based partly on clinical experience rather than evidence alone.

Written by an AI model from this paper’s abstract only and checked automatically against it, but it can still be wrong. It is not medical advice. Read the full paper. See the editorial policy.

Abstract

The full abstract is not shown here because it is protected by the publisher’s copyright. Read it on journals.sagepub.com.

Record from PubMed, a service of the National Library of Medicine.

How to read a single study: what to check before relying on this kind of research.

Terms in this paper: Dry eye. Each links to its definition in the glossary.

A summary of published research, not medical advice. One study rarely settles a question. See the disclaimer and how to read research.

Related studies